ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,814.40
-0.85%
S&P ASX All Technology
3,045.20
-2.07%
Brent Oil
83.76
0.00%
US Dollar vs AUD
1.49209
0.00%
Bitcoin
66,867.30
-0.32%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE
  6. Pfizer Inc (PFE)

  7. Pfizer Inc (PFE) News

PFE

Pfizer (PFE)

Pfizer Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:PFE
DateTimeSourceHeadlineSymbolCompany
17/05/202401:55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:PFEPfizer Inc
17/05/202401:55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:PFEPfizer Inc
16/05/202421:27IH Market NewsChubb Stock Soars 9% with Berkshire Acquisition, AST SpaceMobile jumps 37% on AT&T deal, and More NewsNYSE:PFEPfizer Inc
16/05/202420:00GlobeNewswire Inc.Arvinas and Pfizer Announce Updated Clinical Data from Phase 1b Trial of Vepdegestrant in Combination with Palbociclib (IBRANCE®)NYSE:PFEPfizer Inc
13/05/202422:00PR Newswire (US)Astellas Showcases Scientific Advancements Across its Oncology Portfolio at 2024 ASCO Annual MeetingNYSE:PFEPfizer Inc
13/05/202421:16IH Market NewsArm Sets 2025 Target for AI Chip Development, Amazon and Microsoft Commit Billions to French Investments, and MoreNYSE:PFEPfizer Inc
09/05/202423:01Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNYSE:PFEPfizer Inc
09/05/202421:53IH Market NewsBain Capital in Talks to Acquire PowerSchool; Blackstone Emerges Victorious in Hipgnosis Bidding War, and More NewsNYSE:PFEPfizer Inc
09/05/202405:56Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:PFEPfizer Inc
06/05/202420:45Business WirePfizer Announces New Chief Strategy and Innovation OfficerNYSE:PFEPfizer Inc
01/05/202423:12IH Market NewsCVS Health, Starbucks, Shares Weaker; Pinterest SoarsNYSE:PFEPfizer Inc
01/05/202420:45Business WirePfizer Reports First-Quarter 2024 ResultsNYSE:PFEPfizer Inc
30/04/202408:40Business WireTIVDAK® (tisotumab vedotin-tftv) Receives U.S. FDA Approval to Treat Recurrent or Metastatic Cervical CancerNYSE:PFEPfizer Inc
30/04/202408:40Business WireFDA Grants Full Approval for TIVDAK® to Treat Recurrent or Metastatic Cervical CancerNYSE:PFEPfizer Inc
29/04/202420:45Business WirePfizer Highlights Progress in Accelerating Breakthrough Cancer Medicines at ASCO 2024 Annual MeetingNYSE:PFEPfizer Inc
26/04/202421:48IH Market NewsAnglo American Rejects BHP Group’s Offer, Toyota Invests $1.4 Billion in Indiana, and More NewsNYSE:PFEPfizer Inc
26/04/202420:45Business WireU.S. FDA Approves Pfizer’s BEQVEZ™ (fidanacogene elaparvovec-dzkt), a One-Time Gene Therapy for Adults with Hemophilia BNYSE:PFEPfizer Inc
25/04/202406:37Business WirePfizer Declares Second-Quarter 2024 DividendNYSE:PFEPfizer Inc
24/04/202421:28IH Market NewsCoca-Cola and Microsoft Sign Billion-Dollar Agreement, Apple Event Set for May 7, and More NewsNYSE:PFEPfizer Inc
22/04/202422:08Business WireEuropean Commission Approves Pfizer’s EMBLAVEO® for Patients with Multidrug-Resistant Infections and Limited Treatment OptionsNYSE:PFEPfizer Inc
12/04/202400:00Business WirePfizer Invites Shareholders to Attend Virtual-Only 2024 Annual Meeting of Shareholders on April 25NYSE:PFEPfizer Inc
10/04/202421:13IH Market NewsDelta Generates US$37 Million Profit in Q1, Google and Intel Unveil Cutting-Edge AI Chips, and More NewsNYSE:PFEPfizer Inc
09/04/202420:45Business WirePfizer Announces Positive Top-Line Results from Phase 3 Study of ABRYSVO® in Adults Aged 18 to 59 at Increased Risk for RSV DiseaseNYSE:PFEPfizer Inc
09/04/202402:44PR Newswire (US)ALTIVIA Appoints Scott Barnum as Director of Manufacturing and Dean Hale as Corporate Engineering ManagerNYSE:PFEPfizer Inc
26/03/202422:20IH Market NewsSuper Micro Computer and Seagate Shares Surge on Analyst Optimism in Pre-Market Trading, and Latest NewsNYSE:PFEPfizer Inc
21/03/202422:17IH Market NewsApple Pre-Market Drop Due to Antitrust Threats, Surprising Profit Boosts Micron Shares, and Latest Market UpdatesNYSE:PFEPfizer Inc
21/03/202401:00Business WirePfizer Invites Public to View and Listen to Webcast of May 1 Conference Call with AnalystsNYSE:PFEPfizer Inc
19/03/202422:33IH Market NewsUnilever Initiates Ice Cream Division Spin-Off and Announces Job Cuts; Berkshire Ramps Up Share Buyback Efforts, and MoreNYSE:PFEPfizer Inc
18/03/202422:10IH Market NewsApple & Google in Talks for Gemini AI on iPhone, Nvidia’s GTC Conference Today, and Latest NewsNYSE:PFEPfizer Inc
13/03/202419:00Business WireEuropean Commission Approves Pfizer’s PREVENAR 20® to Help Protect Infants and Children Against Pneumococcal DiseaseNYSE:PFEPfizer Inc
 Showing the most relevant articles for your search:NYSE:PFE

Your Recent History

BIT
I09016
Intesa Sanpaolo
USOTC
CNCN
Chun Can Capital (CE)
USOTC
CMBXF
Cambium Global Timberlan... (CE)
COIN
ABSTBTC
Abitshadow Token
LSE
93QV
Investec Bnk 27
UNSW3
LBRETH
LBR [Lybra Finance]
EU
T729S
T729S
MRTX
ZESTETH
Zest Token
BIT
UC24CL
Unicredit Bank
GATE
ARSWUSDT
ArthSwap Token
BIT
UC8VLR
Unicredit Bank
NASDAQ
UCBHQ
TSX
BAM.PR.T
Brookfield Asset Managem...
EU
P117S
P117S
NYSE
ZB-A
Zions Bancorporation NA
COIN
XCPBTC
Counterparty
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved